The lady pulls in at least $1 million yearly in her "profession."
She has a very impressive professional corporate vitae:
BOARD OF DIRECTORS MEMBERSHIPS*
2005-2009: Former Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee, MDRNA, Inc.
2004-2005: Former Director, Novavax, Inc.
2003-Present: Director, Chairman of Corporate Governance Committee and Member of Compensation Committee, Dendreon Corp.
2003-Present: Director, Member of Compensation Committee and Member of Nominating & Governance Committee, Dyax Corp.
2001-Present: Director, Esperion Therapeutics Inc.
2001-2003: Director and Member of Planning Committee, WellPoint Inc.
2000-Present: Former Director, Curis Inc., Prior to reverse acquisition with Creative BioMolecules Inc.
2000-Present: Director, Corvas International, Inc
2000-2004: Former Director, Cubist Pharmaceuticals Inc.
2000-Present: Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee, Curis Inc.
1994-Present: Lead Director, Chairman of Corporate Governance & Nominating Committee and Member of Compensation Committee, Emmis Communications Corp.
Director: Golden State Foods Corporation
Director: Emmis Operating Company
Member of Strategic Advisory Board, MDRNA, Inc.
http://investing.businessweek.com/...
Interesting little note from Investing Businessweek:
This person is connected to 76 board members in 10 different organizations across 13 different industries.
Um, that sort of gives me the impression that you don't want to mess with Susan Bayh.
And the recent Citizens United decision may have played a large role in hubby Evan Bayh's decision not to run for re-election as U.S. Senator from Indiana. With all that corporate clout behind them, he could be handed the U.S. presidency in 2016, if not 2012, nice comeback for someone who might be tiffed because he wasn't Obama'a VP choice in 2008.
Comments are closed on this story.